Excimer laser treatment of hyperopia with a 9-mm ablation zone

M. Azzolini, P. Vinciguerra, D. Epstein, P. Radice, G. Bailo, V. De Molfetta

Research output: Contribution to journalArticle

Abstract

Purpose. To develop an ablation algorithm for hyperopia that results in greater precision, less regression and better visual acuity than previous excimer strategies. Methods. A Nidek EC 5000 laser with a 5.5-mm optical zone (O.Z.) and a 3.5-mm peripheral blending zone was used, making for a total zone diameter of 9.0 mm. The central corneal remains unablated. The algorithm provides for smooth blending transitions between the ablated zone and both the untreated central and peripheral areas. The unit, working at 46 Hz, utilizes a rotating scanning slit. 18 eyes of 14 patients (26-51 years old) were treated for a mean hyperopia of +4.36 ± 2.32 D. Minimum follow-up time was 6 months. No topical corticosteroids were given postoperatively. Emmetropia was not always aimed at. Results. At 1 month postoperatively, 44.4% of the eyes were within ±0.50 D of intended correction, 38.8% within ±1.0 D, and 16.6% within 2.0 D. At 3 months the corresponding figures were 38.8%, 44.4% and 16.6%, and a 6 months 33.3%, 38.8% and 27.2%. Mean regression for the whole group was 1.8 D by 6 months. Recovery of best-corrected visual acuity (BCVA) was achieved by day 2 in 17 of the 18 eyes. No Snellen lines were lost in any eye. Maximum peripheral haze was 1+. Conclusions. The results indicate that this new algorithm, with its very large O.Z., leads to less regression and faster recovery of BCVA than previously reported for excimer treatment of hyperopia.

Original languageEnglish
JournalInvestigative Ophthalmology and Visual Science
Volume37
Issue number3
Publication statusPublished - Feb 15 1996

Fingerprint

Hyperopia
Excimer Lasers
Visual Acuity
Emmetropia
Therapeutics
Adrenal Cortex Hormones
Lasers

ASJC Scopus subject areas

  • Ophthalmology

Cite this

Azzolini, M., Vinciguerra, P., Epstein, D., Radice, P., Bailo, G., & De Molfetta, V. (1996). Excimer laser treatment of hyperopia with a 9-mm ablation zone. Investigative Ophthalmology and Visual Science, 37(3).

Excimer laser treatment of hyperopia with a 9-mm ablation zone. / Azzolini, M.; Vinciguerra, P.; Epstein, D.; Radice, P.; Bailo, G.; De Molfetta, V.

In: Investigative Ophthalmology and Visual Science, Vol. 37, No. 3, 15.02.1996.

Research output: Contribution to journalArticle

Azzolini, M, Vinciguerra, P, Epstein, D, Radice, P, Bailo, G & De Molfetta, V 1996, 'Excimer laser treatment of hyperopia with a 9-mm ablation zone', Investigative Ophthalmology and Visual Science, vol. 37, no. 3.
Azzolini, M. ; Vinciguerra, P. ; Epstein, D. ; Radice, P. ; Bailo, G. ; De Molfetta, V. / Excimer laser treatment of hyperopia with a 9-mm ablation zone. In: Investigative Ophthalmology and Visual Science. 1996 ; Vol. 37, No. 3.
@article{a568c61ec9f34127a3b1b9f93313a3f2,
title = "Excimer laser treatment of hyperopia with a 9-mm ablation zone",
abstract = "Purpose. To develop an ablation algorithm for hyperopia that results in greater precision, less regression and better visual acuity than previous excimer strategies. Methods. A Nidek EC 5000 laser with a 5.5-mm optical zone (O.Z.) and a 3.5-mm peripheral blending zone was used, making for a total zone diameter of 9.0 mm. The central corneal remains unablated. The algorithm provides for smooth blending transitions between the ablated zone and both the untreated central and peripheral areas. The unit, working at 46 Hz, utilizes a rotating scanning slit. 18 eyes of 14 patients (26-51 years old) were treated for a mean hyperopia of +4.36 ± 2.32 D. Minimum follow-up time was 6 months. No topical corticosteroids were given postoperatively. Emmetropia was not always aimed at. Results. At 1 month postoperatively, 44.4{\%} of the eyes were within ±0.50 D of intended correction, 38.8{\%} within ±1.0 D, and 16.6{\%} within 2.0 D. At 3 months the corresponding figures were 38.8{\%}, 44.4{\%} and 16.6{\%}, and a 6 months 33.3{\%}, 38.8{\%} and 27.2{\%}. Mean regression for the whole group was 1.8 D by 6 months. Recovery of best-corrected visual acuity (BCVA) was achieved by day 2 in 17 of the 18 eyes. No Snellen lines were lost in any eye. Maximum peripheral haze was 1+. Conclusions. The results indicate that this new algorithm, with its very large O.Z., leads to less regression and faster recovery of BCVA than previously reported for excimer treatment of hyperopia.",
author = "M. Azzolini and P. Vinciguerra and D. Epstein and P. Radice and G. Bailo and {De Molfetta}, V.",
year = "1996",
month = "2",
day = "15",
language = "English",
volume = "37",
journal = "Investigative Ophthalmology and Visual Science",
issn = "0146-0404",
publisher = "Association for Research in Vision and Ophthalmology Inc.",
number = "3",

}

TY - JOUR

T1 - Excimer laser treatment of hyperopia with a 9-mm ablation zone

AU - Azzolini, M.

AU - Vinciguerra, P.

AU - Epstein, D.

AU - Radice, P.

AU - Bailo, G.

AU - De Molfetta, V.

PY - 1996/2/15

Y1 - 1996/2/15

N2 - Purpose. To develop an ablation algorithm for hyperopia that results in greater precision, less regression and better visual acuity than previous excimer strategies. Methods. A Nidek EC 5000 laser with a 5.5-mm optical zone (O.Z.) and a 3.5-mm peripheral blending zone was used, making for a total zone diameter of 9.0 mm. The central corneal remains unablated. The algorithm provides for smooth blending transitions between the ablated zone and both the untreated central and peripheral areas. The unit, working at 46 Hz, utilizes a rotating scanning slit. 18 eyes of 14 patients (26-51 years old) were treated for a mean hyperopia of +4.36 ± 2.32 D. Minimum follow-up time was 6 months. No topical corticosteroids were given postoperatively. Emmetropia was not always aimed at. Results. At 1 month postoperatively, 44.4% of the eyes were within ±0.50 D of intended correction, 38.8% within ±1.0 D, and 16.6% within 2.0 D. At 3 months the corresponding figures were 38.8%, 44.4% and 16.6%, and a 6 months 33.3%, 38.8% and 27.2%. Mean regression for the whole group was 1.8 D by 6 months. Recovery of best-corrected visual acuity (BCVA) was achieved by day 2 in 17 of the 18 eyes. No Snellen lines were lost in any eye. Maximum peripheral haze was 1+. Conclusions. The results indicate that this new algorithm, with its very large O.Z., leads to less regression and faster recovery of BCVA than previously reported for excimer treatment of hyperopia.

AB - Purpose. To develop an ablation algorithm for hyperopia that results in greater precision, less regression and better visual acuity than previous excimer strategies. Methods. A Nidek EC 5000 laser with a 5.5-mm optical zone (O.Z.) and a 3.5-mm peripheral blending zone was used, making for a total zone diameter of 9.0 mm. The central corneal remains unablated. The algorithm provides for smooth blending transitions between the ablated zone and both the untreated central and peripheral areas. The unit, working at 46 Hz, utilizes a rotating scanning slit. 18 eyes of 14 patients (26-51 years old) were treated for a mean hyperopia of +4.36 ± 2.32 D. Minimum follow-up time was 6 months. No topical corticosteroids were given postoperatively. Emmetropia was not always aimed at. Results. At 1 month postoperatively, 44.4% of the eyes were within ±0.50 D of intended correction, 38.8% within ±1.0 D, and 16.6% within 2.0 D. At 3 months the corresponding figures were 38.8%, 44.4% and 16.6%, and a 6 months 33.3%, 38.8% and 27.2%. Mean regression for the whole group was 1.8 D by 6 months. Recovery of best-corrected visual acuity (BCVA) was achieved by day 2 in 17 of the 18 eyes. No Snellen lines were lost in any eye. Maximum peripheral haze was 1+. Conclusions. The results indicate that this new algorithm, with its very large O.Z., leads to less regression and faster recovery of BCVA than previously reported for excimer treatment of hyperopia.

UR - http://www.scopus.com/inward/record.url?scp=5844422939&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=5844422939&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:5844422939

VL - 37

JO - Investigative Ophthalmology and Visual Science

JF - Investigative Ophthalmology and Visual Science

SN - 0146-0404

IS - 3

ER -